Achieving clinically meaningful quality of life benefits in nocturia takes time: Results from a long ‐term, multicenter phase 3 study of desmopressin in Japanese patients

ConclusionsDesmopressin ODTs (25 and 50  μg) demonstrated long‐term efficacy, improved QoL, and were well tolerated in Japanese male and female patients with nocturia treated for up to 1 year. Clinically meaningful improvements in patients’ QoL, assessed by N‐QoL, sleep quality, and bother, occur later than objective symptom im provements, such as voids.
Source: LUTS: Lower Urinary Tract Symptoms - Category: Urology & Nephrology Authors: Tags: ORIGINAL ARTICLE Source Type: research